Abstract
Purpose
The vesicular acetylcholine transporter (VAChT) is a specific biomarker for imaging presynaptic cholinergic neurons. The syntheses and C-11 labeling of two potent enantiopure VAChT inhibitors are reported here.
Procedures
Two VAChT inhibitors, (±)-2 and (±)-6, were successfully synthesized. A chiral HPLC column was used to resolve the enantiomers from each corresponding racemic mixture for in vitro characterization. The radiosyntheses of (−)-[11C]2 and (−)-[11C]6 from the corresponding desmethyl phenol precursor was accomplished using [11C]methyl iodide or [11C]methyl triflate, respectively.
Results
The synthesis of (−)-[11C]2 was accomplished with 40–50 % radiochemical yield (decay-corrected), SA > 480 GBq/μmol (EOB), and radiochemical purity >99 %. Synthesis of (−)-[11C]6 was accomplished with 5–10 % yield, SA > 140 GBq/μmol (EOB), and radiochemical purity >97 %. The radiosynthesis and dose formulation of each tracer was completed in 55–60 min.
Conclusions
Two potent enantiopure VAChT ligands were synthesized and 11C-labeled with good radiochemical yield and specific activity.
Similar content being viewed by others
Abbreviations
- ACh:
-
Acetylcholine
- Anal:
-
Analysis
- BBB:
-
Brain–blood barrier
- BOC:
-
t-butoxycarbonyl
- BOPCl:
-
Bis(2-oxo-3-oxazolidinyl)-phosphinic chloride
- Bq:
-
Becquerel
- Calcd.:
-
Calculated
- m-CPBA:
-
m-chloroperoxybenzoic acid
- DMF:
-
N,N-dimethylformamide
- DMSO:
-
Dimethylsulfoxide
- EOB:
-
End of bombardment
- EOS:
-
End of synthesis
- HPL, C:
-
High-performance liquid chromatography
- IBVM, :
-
5-Iodobenzovesamicol
- PET:
-
, Positron emission tomography
- rt:
-
Room temperature
- SA:
-
Specific activity
- SPECT:
-
Single-photon emission computed tomography
- TLC:
-
Thin layer chromatography
- TMS:
-
Tetramethylsilane
- TFA:
-
Trifluoroacetic acid
- UV:
-
Ultraviolet
- VAChT:
-
Vesicular acetylcholine transporter
- Vesamicol:
-
Trans-2-(4-phenylpiperidino)cyclohexanol
References
Schliebs R, Arendt T (2006) The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease. J Neural Transm 113:1625–1644
Hilker R, Thomas AV, Klein JC et al (2005) Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology 65:1716–1722
Gilmor ML, Nash NR, Roghani A et al (1996) Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. J Neurosci 16:2179–2190
Prado VF, Martins-Silva C, de Castro BM et al (2006) Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron 51:601–612
Rogers GA, Parsons SM, Anderson DC et al (1989) Synthesis, in vitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogues of trans-2-(4-phenylpiperidino)cyclohexanol (vesamicol). J Med Chem 32:1217–1230
Widen L, Eriksson L, Ingvar M et al (1992) Positron emission tomographic studies of central cholinergic nerve terminals. Neurosci Lett 136:1–4
Bravo D, Parsons SM (2002) Microscopic kinetics and structure-function analysis in the vesicular acetylcholine transporter. Neurochem Int 41:285–289
Kuhl DE, Koeppe RA, Fessler JA et al (1994) In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM. J Nucl Med 35:405–410
Kuhl DE, Minoshima S, Fessler JA et al (1996) In vivo mapping of cholinergic terminals in normal aging, Alzheimer’s disease, and Parkinson’s disease. Ann Neurol 40:399–410
Albin RL, Cross D, Cornblath WT et al (2003) Diminished striatal [123I]iodobenzovesamicol binding in idiopathic cervical dystonia. Ann Neurol 53:528–532
Mazere J, Prunier C, Barret O et al (2008) In vivo SPECT imaging of vesicular acetylcholine transporter using [123I]IBVM in early Alzheimer’s disease. Neuroimaging 40:280–288
Meikle SR, Kench P, Kassiou M et al (2005) Small animal SPECT and its place in the matrix of molecular imaging technologies. Phys Med Biol 50:R45–R61
Jung YW, Frey KA, Mulholland GK et al (1996) Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol. J Med Chem 39:3331–3342
Mulholland GK, Wieland DM, Kilbourn MR et al (1998) [18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses. Synapse 30:263–274
Efange SM, Khare AB, von Hohenberg K et al (2010) Synthesis and in vitro biological evaluation of carbonyl group-containing inhibitors of vesicular acetylcholine transporter. J Med Chem 53:2825–2835
Giboureau N, Som IM, Boucher-Arnold A et al (2010) PET radioligands for the vesicular acetylcholine transporter (VAChT). Curr Top Med Chem 10:1569–1583
Kilbourn MR, Hockley B, Lee L et al (2009) Positron emission tomography imaging of (2R,3R)-5-[18F]fluoroethoxybenzovesamicol in rat and monkey brain: a radioligand for the vesicular acetylcholine transporter. Nucl Med Biol 36:489–493
Mach RH, Voytko ML, Ehrenkaufer RL et al (1997) Imaging of cholinergic terminals using the radiotracer [18F](+)-4-fluorobenzyltrozamicol: in vitro binding studies and positron emission tomography studies in nonhuman primates. Synapse 25:368–380
Tu Z, Efange SM, Xu J et al (2009) Synthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporter. J Med Chem 52:1358–1369
Kawamura K, Shiba K, Tsukada H et al (2006) Synthesis and evaluation of vesamicol analog (−)-O-[11C]methylvesamicol as a PET ligand for vesicular acetylcholine transporter. Ann Nucl Med 20:417–424
Kilbourn MR, Jung YW, Haka MS et al (1990) Mouse brain distribution of a carbon-11 labeled vesamicol derivative: presynaptic marker of cholinergic neurons. Life Sci 47:1955–1963
Petrou M, Frey KA, Kilbourn MR et al (2014) In vivo imaging of human cholinergic nerve terminals with (−)-5-18F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses. J Nucl Med 55:396–404
Padakanti PK, Zhang X, Jin H, et al (2014) In vitro and in vivo characterization of two C-11 labeled PET tracers for vesicular acetylcholine transporter. Mol Imaging Biol. doi:10.1007/s11307-014-0749-9
Li J, Zhang X, Zhang Z et al (2013) Heteroaromatic and aniline derivatives of piperidines as potent ligands for vesicular acetylcholine transporter. J Med Chem 56:6216–6233
Wang W, Cui J, Lu X et al (2011) Synthesis and in vitro biological evaluation of carbonyl group-containing analogues for Sigma-1 receptors. J Med Chem 54:5362–5372
Acknowledgments
This work was supported by NIH grants NS061025, NS075527, and MH092797. The authors thank William H. Margenau and David Ficke in the Cyclotron Facility for radionuclide production. Optical rotation was determined in the laboratory of Dr. Douglas F. Covey in the Department of Molecular Biology and Pharmacology of Washington University.
Conflict of Interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Padakanti, P.K., Zhang, X., Li, J. et al. Syntheses and Radiosyntheses of Two Carbon-11 Labeled Potent and Selective Radioligands for Imaging Vesicular Acetylcholine Transporter. Mol Imaging Biol 16, 765–772 (2014). https://doi.org/10.1007/s11307-014-0748-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-014-0748-x